Combination regimens containing daratumumab for initial diagnosed acquired thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination regimens containing daratumumab for initial diagnosed acquired thrombotic thrombocytopenic purpura

Published:2023-01-13 Issue:2 Volume:55 Page:399-405
ISSN:1573-742X
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Xie Xiang-ting,Xiao Ying-ying,Zhang Ying,Luo Zhi-ming,Luo Yun

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-023-02768-z.pdf

Reference23 articles.

1. Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129(21):2836–2846

2. Dane K, Chaturvedi S (2018) Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura. Hematol Am Soc Hematol Educ Progr 2018(1):539–547

3. Kremer HJ, Coppo P, Lammle B et al (2017) Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers 3:17020

4. Saha M, McDaniel JK, Zheng XL (2017) Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost 15(10):1889–1900

5. Mazepa MA, Park YA, Raval JS (2019) Taking empiricism out of immune thrombotic thrombocytopenic purpura: current and future treatment strategies. Transfus Med Rev 33(4):248–255

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of daratumumab in multiresistant immune‐mediated thrombotic thrombocytopenic purpura;British Journal of Haematology;2024-09-04

2. Plasma cell‐directed therapy strategies in immune‐mediated thrombotic thrombocytopenic purpura (iTTP);Transfusion;2024-01-18

3. Successful Use of Bortezomib in an Adolescent with Refractory TTP;Case Reports in Hematology;2023-11-25

4. Bortezomib in relapsed/refractory immune thrombotic thrombocytopenic purpura: A single‐centre retrospective cohort and systematic literature review;British Journal of Haematology;2023-08-12

5. Daratumumab for refractory immune‐mediated thrombotic thrombocytopenic purpura;British Journal of Haematology;2023-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3